This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Cornell University. Active years: 2025.
Company Filing History:
Years Active: 2025
Title: Innovations by Christopher Sales in Corneal Tissue Insertion
Introduction
Christopher Sales is an innovative inventor based in New York, NY (US). He has made significant contributions to the field of ophthalmology, particularly in the area of corneal tissue insertion. His work focuses on improving the handling characteristics of delicate corneal tissues during surgical procedures.
Latest Patents
Christopher Sales holds a patent for a "Temporary synthetic carrier for corneal tissue insertion and tissue delivery." This invention addresses the challenges associated with the fragile Descemet membrane endothelial keratoplasty (DMEK) tissue. The solution temporarily imparts the handling characteristics of corneal stroma, facilitating easier insertion and positioning against the recipient eye's cornea. The device can be configured in multiple ways, including coupling a scaffold with either the endothelial or stromal side of the DMEK graft, or both.
Career Highlights
Christopher Sales has dedicated his career to advancing medical technologies that enhance surgical outcomes. His innovative approach to corneal tissue handling has the potential to improve the success rates of eye surgeries. He is affiliated with Cornell University, where he continues to contribute to research and development in this critical area of medicine.
Collaborations
Christopher collaborates with fellow researcher David Putnam, working together to explore new methodologies and technologies in the field of ophthalmology.
Conclusion
Christopher Sales is a notable inventor whose work in corneal tissue insertion has the potential to transform surgical practices. His innovative solutions are paving the way for advancements in eye care and improving patient outcomes.